Leydig, Voit & Mayer, Ltd.
Combination therapy using bispecific anti-c-Met/anti-EGFR antibody and c-Src inhibitor
Pharmaceutical composition including a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor and a method of preventing and/or treating cancer including co-administering a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor to a subject in need thereof.
SAMSUNG ELECTRONICS CO., LTD.
A C C A A C C C A C A A C
A61P C07K C07K A61K A61K C07K C07K C07K A61K C07K A61K A61K C07K
inventional additional additional inventional inventional additional additional additional inventional inventional inventional additional additional
Young Jun Jae-woong Powei Kwang Ho Seung Hyun Jung Wook
Koh Hwang Lin Cheong Lee Lee